Skip to main content

Precision targeting tumor cells using cancer-specific InDel mutations with CRISPR-Cas9.

Kwon T, Ra JS, Lee S, Baek IJ, Khim KW, Lee EA, Song EK, Otarbayev D, Jung W, Park YH, Wie M, Bae J, Cheng H, Park JH, Kim N, Seo Y, Yun S, Kim HE, Moon HE, Paek SH, Park TJ, Park YU, Rhee H, Choi JH, Cho SW, Myung K
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9). pii: 2103532119. doi: 10.1073/pnas.2103532119. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.

Antibodies from Article